Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Therapeutic Effect of Y-27632 on Tumorigenesis and Cisplatin-Induced Peripheral Sensory Loss through RhoA-NF-κB.

Zhu Y, Howard GA, Pittman K, Boykin C, Herring LE, Wilkerson EM, Verbanac K, Lu Q.

Mol Cancer Res. 2019 Sep;17(9):1910-1919. doi: 10.1158/1541-7786.MCR-19-0024. Epub 2019 Jun 12.

PMID:
31189689
2.

An Evaluation of a Rural Community-Based Breast Education and Navigation Program: Highlights and Lessons Learned.

Torres E, Richman AR, Schreier AM, Vohra N, Verbanac K.

J Cancer Educ. 2019 Apr;34(2):277-284. doi: 10.1007/s13187-017-1298-0.

PMID:
29150748
3.

The Short-Term Effect of Weight Loss Surgery on Volumetric Breast Density and Fibroglandular Volume.

Vohra NA, Kachare SD, Vos P, Schroeder BF, Schuth O, Suttle D, Fitzgerald TL, Wong JH, Verbanac KM.

Obes Surg. 2017 Apr;27(4):1013-1023. doi: 10.1007/s11695-016-2415-6.

4.

Elevated MicroRNA-33 in Sarcoidosis and a Carbon Nanotube Model of Chronic Granulomatous Disease.

Barna BP, McPeek M, Malur A, Fessler MB, Wingard CJ, Dobbs L, Verbanac KM, Bowling M, Judson MA, Thomassen MJ.

Am J Respir Cell Mol Biol. 2016 Jun;54(6):865-71. doi: 10.1165/rcmb.2015-0332OC.

5.

A non-tight junction function of claudin-7-Interaction with integrin signaling in suppressing lung cancer cell proliferation and detachment.

Lu Z, Kim DH, Fan J, Lu Q, Verbanac K, Ding L, Renegar R, Chen YH.

Mol Cancer. 2015 Jun 17;14:120. doi: 10.1186/s12943-015-0387-0.

6.

Selective preoperative magnetic resonance imaging in women with breast cancer: no reduction in the reoperation rate.

Weber JJ, Bellin LS, Milbourn DE, Verbanac KM, Wong JH.

Arch Surg. 2012 Sep;147(9):834-9. doi: 10.1001/archsurg.2012.1660.

PMID:
22987175
7.

Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.

Verbanac KM, Min CJ, Mannie AE, Lu J, O'Brien KF, Rosman M, Tafra L; ECU/AAMC Sentinel Node Study Group.

Ann Surg Oncol. 2010 Oct;17 Suppl 3:368-77. doi: 10.1245/s10434-010-1262-2. Epub 2010 Sep 19.

PMID:
20853060
8.

American Society of Clinical Oncology-recommended surveillance and physician specialty among long-term breast cancer survivors.

Hollowell K, Olmsted CL, Richardson AS, Pittman HK, Bellin L, Tafra L, Verbanac KM.

Cancer. 2010 May 1;116(9):2090-8. doi: 10.1002/cncr.25038.

9.
10.

Real-time PCR to determine transgene copy number and to quantitate the biolocalization of adoptively transferred cells from EGFP-transgenic mice.

Joshi M, Keith Pittman H, Haisch C, Verbanac K.

Biotechniques. 2008 Sep;45(3):247-58. doi: 10.2144/000112913.

11.
12.

The current status of xenotransplantation.

Rebellato LM, Verbanac KM, Haisch CE.

Curr Surg. 2005 Sep-Oct;62(5):481-8. Review. No abstract available.

PMID:
16125603
13.

Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis.

Backus J, Laughlin T, Wang Y, Belly R, White R, Baden J, Justus Min C, Mannie A, Tafra L, Atkins D, Verbanac KM.

J Mol Diagn. 2005 Aug;7(3):327-36.

14.

Characterization of Lewis lung clonal variants in a model of syngeneic pulmonary murine metastases.

Storey BT, Pittman HK, Christian JF, Haisch CE, Verbanac KM.

Clin Exp Metastasis. 2004;21(3):265-73. Erratum in: Clin Exp Metastasis. 2004;21(7):663.

PMID:
15387377
15.

Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.

Posekany KJ, Pittman HK, Swanson MS, Haisch CE, Verbanac KM.

Anticancer Res. 2004 Mar-Apr;24(2B):605-12.

16.
17.

Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer.

Tafra L, Verbanac KM, Lannin DR.

Am J Surg. 2001 Oct;182(4):312-5.

PMID:
11720661
18.

Molecular detection of breast cancer markers.

Verbanac KM.

Mol Diagn. 2001 Jun;6(2):73-7. No abstract available.

PMID:
11468692
19.

Human T-cell-porcine endothelial cell interactions induce human Th1 cytokines and porcine activation markers.

Coleman TS, Pittman HK, Purser SM, Haisch CE, Verbanac KM.

J Surg Res. 2001 May 15;97(2):184-91.

PMID:
11341797
20.

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.

Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R.

Ann Surg. 2001 Jan;233(1):51-9.

21.
22.

Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.

Thomas JM, Neville DM, Contreras JL, Eckhoff DE, Meng G, Lobashevsky AL, Wang PX, Huang ZQ, Verbanac KM, Haisch CE, Thomas FT.

Transplantation. 1997 Jul 15;64(1):124-35.

PMID:
9233712
23.

Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.

Thomas J, Kasten-Jolly J, Verbanac K, Smith JP, Carver M, Gross U, Rebellato L, Thomas F, Haisch C.

Transplant Proc. 1995 Feb;27(1):686-8. No abstract available.

PMID:
7879146
24.

Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.

Thomas J, Kasten-Jolly J, Verbanac K, Smith JP, Carver M, Gross U, Rebellato L, Thomas F, Haisch C.

Transplant Proc. 1995 Feb;27(1):166-8. No abstract available.

PMID:
7878957
25.

The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.

Thomas JM, Verbanac KM, Smith JP, Kasten-Jolly J, Gross U, Rebellato LM, Haisch CE, Carver FM, Thomas FT.

Transplantation. 1995 Jan 27;59(2):245-55.

PMID:
7839448
26.

Veto cells in transplantation tolerance.

Thomas JM, Verbanac KM, Carver FM, Kasten-Jolly J, Haisch CE, Gross U, Smith JP.

Clin Transplant. 1994 Apr;8(2 Pt 2):195-203. Review.

PMID:
8019036
27.

A role for transforming growth factor-beta in the veto mechanism in transplant tolerance.

Verbanac KM, Carver FM, Haisch CE, Thomas JM.

Transplantation. 1994 Mar 27;57(6):893-900.

PMID:
8154038
28.

A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin.

Rebellato LM, Gross U, Verbanac KM, Thomas JM.

Transplantation. 1994 Mar 15;57(5):685-94.

PMID:
7908150
29.
30.
31.

Generation of rabbit anti-lymphocyte monoclonal antibodies.

Verbanac KM, Gross U, Rebellato LM, Thomas JM.

Transplant Proc. 1993 Feb;25(1 Pt 1):837-8. No abstract available.

PMID:
8438497
32.

Donor bone marrow infusion suppresses alloantibody response in RATG-treated recipients: a correlate of long survival.

Thomas JM, Carver FM, Cunningham PR, Gross U, Verbanac KM, Rebellato LM, Riley R, Thomas FT.

Transplant Proc. 1993 Feb;25(1 Pt 1):342-3. No abstract available.

PMID:
8438326
33.

Immunosuppressive and nonimmunosuppressive rabbit antihuman T-lymphocyte antibodies exhibit different recognition patterns to T-cell membrane antigens.

Rebellato LM, Verbanac KM, Carver FM, Thomas JM.

Transplant Proc. 1991 Feb;23(1 Pt 2):1117-9. No abstract available.

PMID:
1824890
34.

Biosynthesis, processing, and secretion of M and Z variant human alpha 1-antitrypsin.

Verbanac KM, Heath EC.

J Biol Chem. 1986 Jul 25;261(21):9979-89.

35.

Biosynthesis and processing of rat alpha 1-antitrypsin.

Verbanac KM, Heath EC.

Arch Biochem Biophys. 1983 May;223(1):149-57.

PMID:
6602589
36.

Role of the H-2 complex in preimplantation mouse embryo development.

Goldbard SB, Verbanac KM, Warner CM.

Biol Reprod. 1982 May;26(4):591-6.

PMID:
7082730
37.

Genetic analysis of H-2 linked gene(s) affecting early mouse embryo development.

Goldbard SB, Verbanac KM, Warner CM.

J Immunogenet. 1982 Apr;9(2):77-82.

PMID:
6806393

Supplemental Content

Loading ...
Support Center